TNKase is administered as a single intravenous bolus over 5 seconds. The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The study examined 352 individuals with stroke ...
Triage from the emergency department to an angiographic operating room requires activation of specially trained personnel and patient transport to remote locations in the hospital facility. To ...
Recent research has revealed compelling evidence supporting tenecteplase as a more effective treatment for ischemic strokes compared to traditional alteplase therapy. This discovery could mark a major ...
For acute ischemic stroke within 48 hours of onset, the novel sublingual combination of edaravone (Radicava) with dexborneol appeared to dramatically improve functional outcomes in the phase III TASTE ...
Company to Highlight Imaging Biomarkers for Cytoprotection and Post Hoc Analysis from Phase 2 RESCUE Clinical Trial; RNS60 Led to Shorter Hospital Stays in Acute Ischemic Stroke Subjects Enrolled with ...
Background The presence of a coincident intracranial aneurysm (CIA) on the target vessel of patients undergoing mechanical thrombectomy (MT) for acute ischemic stroke (AIS) poses challenges, as the ...
Since 2022, the hospital has not been providing the life-saving, clot-dissolving TPA drug and instead sending stroke patients ...
Share on Pinterest Adding blood thinners to clot-busting medication after a stroke does not appear to improve the outcomes, according to a new study. credit: szjphoto/Getty Images. About 15 million ...
Share on Pinterest New research shows an endovascular thrombectomy helps create new connections around dead brain tissue after a stroke. BSIP/Universal Images Group via Getty Images New research shows ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results